SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Primary objective:
To compare metabolic control as measured by Blood Glucose (BG) upon arising from bed (7:00 am
- 12:00 pm) in type 1 Diabetes mellitus patients who skip the morning meal during treatment
with MDI basal/bolus insulin: Difference of change of blood glucose between 7:00 am and 11:00
am between patients on Insulin glargine and NPH insulin.
Secondary objective:
To perform an evaluation between the two patient groups for BG (10:00 pm and 12:00 pm) as
well as for serum insulin, free fatty acid levels and β-hydroxybutyrate (7:00 am - 12:00 pm).